Related Experiment Video
Updated: Aug 6, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Cost-effectiveness of paediatric rapid genomic testing: a commentary
International Journal for Advancing Practice
|July 22, 2026
Summary
Rapid genomic testing (RGT) offers early diagnosis for critically ill children, improving outcomes. Further research and implementation strategies are needed to integrate RGT into pediatric care.
Area of Science:
- Genetics
- Pediatrics
- Health Economics
Background:
- Genetic disorders in children can cause severe illness and mortality.
- Rapid genomic testing (RGT) aids early diagnosis and treatment, potentially improving outcomes and reducing costs.
- Economic evaluations are crucial for assessing RGT's value in pediatric care.
Purpose of the Study:
- Critically appraise an economic evaluation of RGT strategies in Australian pediatric care.
- Identify limitations in the existing economic evaluation.
- Propose implications for practice and future research.
Main Methods:
- Commentary and critical appraisal of a published economic evaluation.
- Analysis of decision problem, perspective, model structure, costs, and results interpretation.
- Identification of limitations regarding study horizon and outcome measures.
Main Results:
- The economic evaluation appropriately defined the decision problem and parameters.
- Limitations included a short-term study horizon and lack of clinical/quality-of-life outcomes.
- Recent RGT developments and implementation factors require consideration.
Conclusions:
- Addressing limitations in economic evaluations can strengthen the case for RGT.
- Future research should consider implementation barriers, cost-effectiveness for specific conditions, and practitioner training.
- RGT integration into pediatric diagnostic tools requires systemic coordination and accessibility.
Related Concept Videos
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
02:57Real Time RT-PCR
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
The real-time quantification of the number of amplified products is...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...